FDA issues new dosing guide for children using Valcyte
Links shared publicly online about this topic.
- 885total visits
FDA issues new dosing guide for children using Valcyte
fda.gov —
The U.S. Food and Drug Administration is notifying health care professionals of updated dosing recommendations for Valcyte (valganciclovir) oral tablets and solution used by children and adolescents receiving a kidney or heart transplant. The update is intended to prevent drug overdosing of children with low body weight, low body surface area, and very low serum creatinine. The revised dosing instructions now appear in the product's label.
View full resource at fda.gov
Most Recently Shared on September 15, 2010 at 5:56 pm By:
FDA issues new dosing guide for children using Valcyte. http://ow.ly/2ELnr
Also Shared By:
MHA News Now: FDA issues new pediatric dosing recommendations for antiviral drug
mhanewsnow.typepad.com — “The Food and Drug Administration has issued new pediatric dosing guidelines for Valcyte (valganciclovir hydrochloride), an antiviral medication used to help prevent cytomegalovirus disease in children between the ages of 4 months and 16 who have undergone a kidney or...” View full resource at mhanewsnow.typepad.com
Most Recently Shared on September 20, 2010 at 2:06 am By:
MS Hospital Assoc. Health Organization
FDA issues new pediatric dosing recommendations for antiviral drug http://bit.ly/bMeWBX
Advertisement
Sandeep Pulim MD
@MDLinx
FDA issues new dosing guide for children using Valcyte. http://ow.ly/2ELjC
1 year ago...